My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Glycosaminoglycans delay the progression of nephropathy in NIDDM.

    Solini A, Vergnani L, Ricci F, Crepaldi G.

    Diabetes Care. 1997 May;20(5):819-23.PMID: 9135948 [PubMed - indexed for MEDLINE]Related articles

    2.

    Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.

    Skrha J, Perusicová J, Pont'uch P, Oksa A.

    Diabetes Res Clin Pract. 1997 Oct;38(1):25-31.PMID: 9347243 [PubMed - indexed for MEDLINE]Related articles

    3.

    Incipient and overt diabetic nephropathy in African Americans with NIDDM.

    Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH.

    Diabetes Care. 1994 Apr;17(4):297-304.PMID: 8026285 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

    Ahmad J, Siddiqui MA, Ahmad H.

    Diabetes Care. 1997 Oct;20(10):1576-81.PMID: 9314638 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

    Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

    Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G; DAIS Investigators.

    Am J Kidney Dis. 2005 Mar;45(3):485-93.PMID: 15754270 [PubMed - indexed for MEDLINE]Related articles

    7.

    Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study.

    Sasso FC, Carbonara O, Persico M, Iafusco D, Salvatore T, D'Ambrosio R, Torella R, Cozzolino D.

    Diabetes Care. 2002 Nov;25(11):1909-13.PMID: 12401731 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    One year course of oral sulodexide in the management of diabetic nephropathy.

    Achour A, Kacem M, Dibej K, Skhiri H, Bouraoui S, El May M.

    J Nephrol. 2005 Sep-Oct;18(5):568-74.PMID: 16299683 [PubMed - indexed for MEDLINE]Related articles

    9.

    Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study.

    Smulders YM, Rakic M, Stehouwer CD, Weijers RN, Slaats EH, Silberbusch J.

    Diabetes Care. 1997 Jun;20(6):999-1005.PMID: 9167114 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

    Diabetes. 1997 Jul;46(7):1182-8.PMID: 9200654 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

    Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.

    Diabetes Care. 1999 Jul;22(7):1176-80.PMID: 10388985 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [The effect of glycosaminoglycan sulodexide on albuminuria in patients with diabetes mellitus]

    Oksa A, Pontuch P, Kratochvilova H.

    Bratisl Lek Listy. 1999 Sep;100(9):486-9. Slovak. PMID: 10645038 [PubMed - indexed for MEDLINE]Related articles

    13.

    Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.

    Gambaro G, Kinalska I, Oksa A, Pont'uch P, Hertlová M, Olsovsky J, Manitius J, Fedele D, Czekalski S, Perusicová J, Skrha J, Taton J, Grzeszczak W, Crepaldi G.

    J Am Soc Nephrol. 2002 Jun;13(6):1615-25.PMID: 12039991 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

    J Nephrol. 2001 Nov-Dec;14(6):461-71.PMID: 11783602 [PubMed - indexed for MEDLINE]Related articles

    15.

    A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy.

    Dedov I, Shestakova M, Vorontzov A, Palazzini E.

    Nephrol Dial Transplant. 1997 Nov;12(11):2295-300.PMID: 9394314 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.

    Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC.

    Diabetes Care. 1998 Jul;21(7):1154-8.PMID: 9653611 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).

    [No authors listed]

    Diabetes. 2001 Apr;50(4):843-50.PMID: 11289051 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.

    Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P.

    Diabetes. 2000 Mar;49(3):476-84.PMID: 10868971 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.

    Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimäki T.

    Nephron. 1998 Sep;80(1):17-24.PMID: 9730698 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity